In a rare admission, Chinese official says home-grown vaccines’ effectiveness low

The effectiveness rate of a coronavirus vaccine from Sinovac at preventing symptomatic infections has been found to be as low as 50.4%. By comparison, the vaccine made by Pfizer has been found to be 97% effective.

April 11, 2021 12:19 pm | Updated 12:19 pm IST - Beijing

Employees pick up vials containing CoronaVac, Sinovac’s vaccine against the coronavirus disease (COVID-19), as they put them in trays before boxing.

Employees pick up vials containing CoronaVac, Sinovac’s vaccine against the coronavirus disease (COVID-19), as they put them in trays before boxing.

In a rare admission of the weakness of Chinese coronavirus vaccines , the country’s top disease control official says their effectiveness is low and the government is considering mixing them to give them a boost.

Chinese vaccines “don't have very high protection rates,” said the director of the China Centers for Disease Control, Gao Fu, at a conference Saturday in the southwestern city of Chengdu.

Beijing has distributed hundreds of millions of doses in other countries while also trying to promote doubt about the effectiveness of Western vaccines.

Also read: Explained | What we know about China-made vaccines

“It’s now under formal consideration whether we should use different vaccines from different technical lines for the immunization process,” Mr. Gao said.

The effectiveness rate of a coronavirus vaccine from Sinovac, a Chinese developer, at preventing symptomatic infections has been found to be as low as 50.4% by researchers in Brazil . By comparison, the vaccine made by Pfizer has been found to be 97% effective.

Beijing has yet to approve any foreign vaccines for use in China, where the coronavirus emerged in late 2019.

Mr. Gao gave no details of possible changes in strategy but mentioned mRNA, a previously experimental technique used by Western vaccine developers while China’s drug makers used traditional technology.

“Everyone should consider the benefits mRNA vaccines can bring for humanity,” Mr. Gao said. “We must follow it carefully and not ignore it just because we already have several types of vaccines already.”

Mr. Gao previously raised questions about the safety of mRNA vaccines. He was quoted by the official Xinhua News Agency as saying in December he couldn’t rule out negative side effects because they were being used for the first time on healthy people.

Chinese state media and popular health and science blogs also have questioned the safety and effectiveness of the Pfizer vaccine, which uses mRNA.

As of April 2, some 34 million people have received both of the two doses required by Chinese vaccines and about 65 million received one, according to Mr. Gao.

Experts say mixing vaccines, or sequential immunization, might boost effectiveness rates. Trials around the world are looking at mixing of vaccines or giving a booster shot after a longer time period. Researchers in Britain are studying a possible combination of Pfizer and AstraZeneca vaccines.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.